Literature DB >> 11866272

Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct.

Mari M Calvo1, Luis Bujanda, Angel Calderón, Iñaki Heras, José L Cabriada, Antonio Bernal, Victor Orive, Elena Astigarraga.   

Abstract

OBJECTIVE: To date, ERCP has been the reference technique in the diagnosis of pancreatic duct pathology. The aim of the present study was to evaluate the accuracy of magnetic resonance cholangiopancreatography (MRCP), a relatively new, noninvasive diagnostic method, in studying the pancreatic duct.
METHODS: A prospective 15-month study was done of 78 patients with suspected biliopancreatic pathology and indications for ERCP. In all cases, MRCP was performed <72 h before ERCP. Both techniques were used to assess the size of the pancreatic tract (normal or dilated), the presence or absence of obstruction, the level of obstruction where present, and its etiology.
RESULTS: Both techniques found the pancreatic tract to be normal and nondilated in 60 patients. The specificity and sensitivity of MRCP in evaluating the normal pancreatic duct were 98% and 94%, respectively. In nine cases, a stenotic duct of Wirsung was detected (seven at the head of the pancreas and two in the body), with the same correlation being shown by ERCP (sensitivity 100%). The sensitivity and specificity of MRCP relating to diffuse irregular and dilated morphologies of the entire pancreatic duct was 86% and 100%, respectively. Nine patients were diagnosed with pancreatic neoplasms by both techniques, with an accuracy of 100%. Four patients presented chronic pancreatitis, which was correctly diagnosed by MRCP in each case.
CONCLUSIONS: MRCP is an effective technique for evaluating both the normal and diseased duct of Wirsung, and for establishing the underlying pathology.

Entities:  

Mesh:

Year:  2002        PMID: 11866272     DOI: 10.1111/j.1572-0241.2002.05468.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines.

Authors:  Darwin L Conwell; Linda S Lee; Dhiraj Yadav; Daniel S Longnecker; Frank H Miller; Koenraad J Mortele; Michael J Levy; Richard Kwon; John G Lieb; Tyler Stevens; Phillip P Toskes; Timothy B Gardner; Andres Gelrud; Bechien U Wu; Christopher E Forsmark; Santhi S Vege
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

2.  Role of endoscopic retrograde cholangiopancreatography in pancreatic diseases.

Authors:  Dimitrios K Christodoulou; Epameinondas V Tsianos
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Use of carbon dioxide as negative contrast agent for magnetic resonance cholangiopancreatography.

Authors:  Ching-Wen Chen; Yi-Sheng Liu; Chiung-Yu Chen; Hong-Ming Tsai; Shu-Chen Chen; Ming-Tsung Chuang
Journal:  World J Radiol       Date:  2011-02-28

4.  Comparison of diagnostic imaging modalities for the evaluation of pancreatic duct injury in children: a multi-institutional analysis from the Pancreatic Trauma Study Group.

Authors:  Eric H Rosenfeld; Adam Vogel; Robert T Russell; Ilan Maizlin; Denise B Klinkner; Stephanie Polites; Barbara Gaines; Christine Leeper; Stallion Anthony; Megan Waddell; Shawn St Peter; David Juang; Rajan Thakkar; Joseph Drews; Brandon Behrens; Mubeen Jafri; Randall S Burd; Marianne Beaudin; Laurence Carmant; Richard A Falcone; Suzanne Moody; Bindi J Naik-Mathuria
Journal:  Pediatr Surg Int       Date:  2018-08-03       Impact factor: 1.827

5.  Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP.

Authors:  Yun Bian; Li Wang; Chao Chen; Jian-Ping Lu; Jia-Bao Fan; Shi-Yue Chen; Bing-Hui Zhao
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

6.  Oral effervescent agent improving magnetic resonance cholangiopancreatography.

Authors:  Heon-Ju Kwon; Kyoung Won Kim; Kyung A Kang; Mi Sung Kim; So Yeon Kim; Taeyong Park; Jeongjin Lee
Journal:  Quant Imaging Med Surg       Date:  2022-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.